Jaguar Gene Therapy
IL - Lake ForestBiotechnology
Focus: Jaguar Gene Therapy is a public biotechnology company specializing in AAV-based gene therapies, headquartered in Lake Forest, Illinois. The company is focused on developing novel treatments for rare genetic diseases.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at Jaguar Gene Therapy?
AI assessmentJaguar is a high-risk, early-stage gene therapy play suited for career-stage scientists and commercial professionals willing to bet on AAV platform success and rare-disease commercial execution.
Why Work Here
- Early-stage AAV gene therapy platform with potential for significant clinical impact in rare disease indications like SHANK3 haploinsufficiency
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PHASE_1_2
Clinical Trials (1)
NCT06662188JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency
Phase 1/2Help build intelligence for Jaguar Gene Therapy
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.